Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. The systemic treatment of recurrent ovarian cancer revisited;Baert;Ann Oncol,2021
2. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo;Int J Gynecol Cancer,2019
3. PARP inhibitors in the management of ovarian cancer: ASCO guideline;Tew;J Clin Oncol,2020
4. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial;Swisher;Lancet Oncol,2017
5. Efficacy and safety of olaparib monotherapy in germline BRCA 1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy;Domchek;Gynecol Oncol,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献